Advances in Solid Lipid Micro- and Nanoparticle Technology

Dear Colleagues,

Undoubtedly, solid lipid micro- and nanoparticles show strong potential in a number of different therapeutic areas. Their proven safety and the availability of scalable manufacturing techniques rank solid lipid particles among the most attractive technologies. Unfortunately, the intrinsic solid state properties of lipids are detrimental to particle storage stability and sometimes restrict their market appeal. Therefore, in spite of the recorded progress, the solid lipid particle technology still strives to overcome unmet development issues.

This Special Issue aims to cover the most recent research efforts addressing lipid particle technology challenges. Special attention will be dedicated to manufacturing and novel cutting-edge technologies that may help to prevent the well-known issues of lipid materials and could foster the industrial development of these versatile delivery systems. Detailed topics are: advanced manufacturing techniques; new solid lipid particle engineering approaches to enhance stability and delivery performances; new approaches in the use of solid lipid particles for targeted or local drug delivery; technologies addressing delivery of biopharmaceutical products and hydrophilic compounds.

Prof. Stefano Giovagnoli
Prof. Paolo Blasi
Dr. Aurélie Schoubben
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-anonymized peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmaceutics is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.